Uncovering New Approaches to Accelerate GBM Treatment
In recognition of GBM Awareness Day, discover two emerging researchers taking novel approaches to overcome obstacles in treating glioblastoma.
What is your brain tumor story? Click here to share it. Your story matters.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
In recognition of GBM Awareness Day, discover two emerging researchers taking novel approaches to overcome obstacles in treating glioblastoma.
Double your impact toward our $50,000 goal to accelerate high-risk, high-reward research during GBM Awareness Day (7/17).
by Katie Kaiser Smith In 2012, my life was filled with the joys and challenges of raising a one-year-old baby girl and a six-year-old son. But that year also marked
The Society for Neuro-Oncology (SNO)/American Society of Clinical Oncology (ASCO) Central Nervous System (CNS) Metastases Conference brought together leading experts, researchers, and clinicians from around the world to discuss the
A new treatment called vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for people with low-grade gliomas (LGG). This type of brain tumor grows slowly but
by Jenny Williams Jenny was just 11 years old when she learned what a brain tumor diagnosis meant and how it would affect her and her family. Her dad was
The NIH Clinical Center is the nation’s largest hospital devoted entirely to clinical research. Clinician-investigators translate scientific observations and laboratory discoveries into new approaches to diagnosing, treating, and preventing disease.
The American Brain Tumor Association’s 2024 National Conference, September 5-7, was a resounding success, bringing together over 1,300 attendees from across the nation and the globe, virtually and in-person. (Above
Kidney cancer can sometimes bring an unexpected challenge: brain metastases. While patients may hear about this possibility during treatment, the sheer amount of information can feel overwhelming and some details